- Circassia Pharmaceuticals has declared its offer for Aerocrine unconditional and extended the acceptance period until 26 June.

Circassia made a public cash offer of SKr2.55 per share for Aerocrine on 15 May. The acceptance period ended on 11 June.

During the acceptance period 647,106,297 shares have been tendered - approximately 92.6% of the shares and the voting rights in Aerocrine. All conditions for the offer have been fulfilled and Circassia has declared the offer wholly unconditional.

Story provided by